Affinia Therapeutics
Developer of an adeno-associated virus gene therapy platform intended to focus on diseases affecting the central nervous system and muscles. The company's platform helps to design therapies using tool...
Valuation
$145M
Market implied
Share Price
N/A
Total Raised
$210M
Last Round
N/A